Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 2 1Phase 1/2 1

Status

Completed 4Unknown 2Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 4Depression 3Anxiety Disorders 3Neoplasm Metastasis 2Hospice 1Hematologic Neoplasms 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Neoplasms × Psilocybin × Clear all
NCT00302744 2025-03-13

Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Phase 1/2 Completed
12 enrolled

Anxiety Disorders, Depression, Neoplasms

NCT04522804 2024-03-20

HOPE

University of Utah

Phase EARLY_PHASE1 Completed
12 enrolled
Tumor-Agnostic

Neoplasms

NCT00957359 2020-10-20

Psilocybin Cancer Anxiety Study

NYU Langone Health

Phase EARLY_PHASE1 Completed
29 enrolled 59 charts

Anxiety Disorders, Depression, Neoplasms

NCT00465595 2018-07-19

Psychopharmacology of Psilocybin in Cancer Patients

Johns Hopkins University

Phase 2 Completed
56 enrolled 8 charts

Anxiety Disorders, Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡